Cell Cycle Phases and Regulation (2C) - Bio & Biochem

1. A laboratory tests a new compound that selectively inhibits the proteasome in proliferating lymphocytes. After treatment, cells show accumulation of cyclins and other short-lived regulatory proteins, and many cells fail to progress beyond late mitosis. Which phase of the cell cycle is most likely affected by impaired proteasome-dependent degradation in this setting?
   Answer: M phase, because timely destruction of mitotic regulators is required for anaphase and mitotic exit This question evaluates understanding of proteasome-dependent protein degradation in cell cycle regulation, particularly during mitosis. The proteasome degrades ubiquitinated proteins including cyclins and other regulators whose timely destruction is essential for cell cycle progression, especially during mitotic exit when cyclin B and securin must be degraded. Proteasome inhibition causes accumulation of these proteins and prevents progression through late mitosis, as cells cannot degrade cyclin B to exit mitosis or securin to initiate anaphase. The correct answer C identifies M phase as most affected because mitotic progression requires rapid, precisely timed protein degradation. Option A incorrectly suggests proteasomes prevent quiescence; option B wrongly links proteasomes to DNA polymerase; option D incorrectly states proteasome inhibition eliminates cyclin D when it actually causes accumulation. When analyzing proteasome function in cell cycle, focus on phases requiring rapid protein turnover - particularly the metaphase-to-anaphase transition and mitotic exit where APC/C-mediated ubiquitination targets proteins for proteasomal degradation.
2. In an experiment on contact inhibition, cultured cells are grown to confluence. Wild-type cells reduce proliferation, while cells expressing a constitutively active cyclin D–CDK4 complex continue to enter S phase. Which checkpoint control is most likely being overridden?
   Answer: G1 restriction point control of Rb phosphorylation and E2F activation This question tests contact inhibition and restriction point. Principle: Confluence signals halt G1 progression via low cyclin D-CDK4, keeping Rb unphosphorylated and E2F repressed; active complex overrides this. Active cyclin D-CDK4 cells continue S-phase at confluence. Choice B is consistent as it overrides G1 restriction point. Choice A fails, focusing on spindle checkpoint irrelevant to G1, misconstruing inhibition as mitotic. For verification, compare proliferation at density. Strategy: link extracellular signals to internal regulators like Rb-E2F.
3. Investigators transiently overexpressed p16INK4a in dividing keratinocytes. Within 24 hours, cells show decreased phosphorylation of Rb and reduced expression of genes associated with DNA synthesis. Which regulatory mechanism best explains the observed changes?
   Answer: Inhibition of CDK4/6 activity, preventing cyclin D-dependent Rb phosphorylation and delaying G1/S progression This question evaluates understanding of p16INK4a as a CDK inhibitor that regulates the G1/S transition by preventing Rb phosphorylation. p16INK4a specifically inhibits CDK4 and CDK6, preventing their association with cyclin D and thus blocking Rb phosphorylation, which keeps Rb bound to E2F and prevents S-phase gene expression. Overexpression of p16INK4a therefore causes G1 arrest with hypophosphorylated Rb and reduced DNA synthesis genes, as observed in the experiment. The correct answer A accurately describes this mechanism - inhibition of CDK4/6 preventing cyclin D-dependent Rb phosphorylation. Option B incorrectly suggests CDK1 activation; option C wrongly involves APC/C in G1; option D incorrectly links p16 to telomerase. When analyzing CDK inhibitor questions, match the specific inhibitor to its target: p16INK4a inhibits CDK4/6, p21 inhibits multiple CDKs, and p27 primarily targets CDK2.
4. A lab uses a fluorescent reporter that accumulates only when CDK2 activity is high. Following growth factor addition to quiescent cells, reporter signal rises and cells begin DNA synthesis. If a CDK2 inhibitor is added at the time of growth factor addition, which result is most expected?
   Answer: Reduced initiation of S phase due to impaired G1/S CDK activity This question assesses CDK2's role in S-phase entry. Principle: CDK2 activation post-growth factors drives G1/S via Rb phosphorylation and E2F; inhibition reduces this, blocking DNA synthesis. Inhibitor at growth factor addition prevents reporter rise and synthesis. Choice B is consistent as impaired CDK2 halts S-phase initiation. Choice A fails, suggesting mitosis bypass, but CDK2 is G1/S-specific, a misconception equating all CDKs to M-phase. In similar assays, use activity reporters for phase timing. Strategy: match CDK isoform to cyclin partner and transition.
5. A DNA damage experiment uses a fluorescent reporter for p21 expression. After treatment with a double-strand break inducer, p21 increases in wild-type cells but not in cells expressing a dominant-negative p53. Which cell-cycle effect is most expected in the dominant-negative p53 cells relative to wild-type?
   Answer: Reduced G1/S arrest with increased entry into S phase despite damage This question tests understanding of cell cycle regulation, specifically the G1/S checkpoint in response to DNA damage. The principle assessed is that p53, activated by DNA damage, induces expression of p21, a CDK inhibitor that halts progression from G1 to S phase to allow repair. In this experiment, wild-type cells exhibit increased p21 after double-strand break induction, while dominant-negative p53 cells do not, indicating impaired p53 function and thus no p21-mediated arrest. The correct answer, reduced G1/S arrest with increased entry into S phase despite damage, aligns with this mechanism because without p21, CDK4/6 remains active, permitting unchecked cell cycle progression. A common distractor, such as more robust G1/S arrest, fails because it mistakenly assumes dominant-negative p53 enhances rather than impairs checkpoint function, confusing inhibitory mutations with hyperactivity. To verify similar questions, recall that p53 acts as the 'guardian of the genome' by promoting arrest or apoptosis in damaged cells. A useful strategy is to trace the pathway from damage signal to effector proteins like p21 and predict outcomes based on disruptions at each step.
6. A DNA-damaging agent was applied to cultured cells, and CHK1 kinase activity increased within 30 minutes. In parallel, investigators observed reduced CDK1 activity and a delayed entry into mitosis. A second group of cells expressed a dominant-negative CHK1, and these cells showed less delay in mitotic entry after damage. Based on this scenario, which regulatory protein interaction is most involved in delaying mitosis?
   Answer: CHK1-mediated inhibition of Cdc25, maintaining CDK1 in an inhibited state This question examines the DNA damage response at the G2/M checkpoint involving CHK1 signaling. The core principle is that DNA damage activates CHK1, which phosphorylates and inhibits Cdc25, maintaining CDK1 in an inactive phosphorylated state to delay mitosis. The experiment shows CHK1 activation post-damage reduces CDK1 activity and delays mitosis, with dominant-negative CHK1 diminishing this delay. The correct answer, CHK1-mediated inhibition of Cdc25 keeping CDK1 inhibited, is fitting as it directly explains the mechanism preventing premature mitosis. A distractor like CHK1 activating APC/C fails by incorrectly linking CHK1 to mitotic exit rather than entry control, misconstruing checkpoint targets. In similar questions, map kinase cascades to their effectors, like CHK1 to Cdc25 for G2/M. A transferable strategy is to compare wild-type and mutant responses to identify the disrupted pathway's function.
7. Researchers engineered a cancer cell line to express a nondegradable cyclin B variant that cannot be targeted for ubiquitin-mediated destruction. Cells progress through S phase normally, but microscopy reveals persistent condensed chromosomes and intact mitotic spindles without completion of cytokinesis. Based on the scenario, what outcome is most consistent with the described regulatory disruption?
   Answer: Failure to exit mitosis due to sustained CDK1 activity from persistent cyclin B This question assesses knowledge of how cyclin B degradation is required for mitotic exit and the consequences of preventing this degradation. During normal mitosis, cyclin B must be degraded by the APC/C to inactivate CDK1 and allow cells to exit mitosis, complete cytokinesis, and return to interphase. The engineered nondegradable cyclin B variant maintains CDK1 activity, keeping cells stuck in a mitotic state with condensed chromosomes and intact spindles but unable to complete division. The correct answer B accurately describes this phenotype - failure to exit mitosis due to sustained CDK1 activity from persistent cyclin B. Option A incorrectly focuses on G1 and Rb; option C wrongly suggests S phase problems when the cells progress through S normally; and option D incorrectly invokes p53 and G2 arrest when the problem is in mitotic exit. When evaluating questions about cyclin degradation, remember that cyclin destruction is essential for CDK inactivation and phase transitions, particularly the metaphase-to-anaphase transition (cyclin B) and mitotic exit.
8. In yeast cells, investigators introduced a mutation that prevents phosphorylation (and thus inactivation) of Cdc25, a phosphatase that activates CDK1 by removing inhibitory phosphates. Following exposure to replication stress (nucleotide depletion), mutant cells entered mitosis more readily than wild-type cells and exhibited increased chromosome segregation errors. What outcome is most consistent with this checkpoint disruption?
   Answer: Premature G2/M entry despite incomplete DNA replication This question probes the G2/M checkpoint and regulation of CDK1 activation in response to replication stress. The principle is that replication stress inactivates Cdc25 via phosphorylation, preventing CDK1 dephosphorylation and thus delaying mitotic entry to allow repair. In the yeast model, the mutation keeps Cdc25 active, causing premature mitosis under nucleotide depletion with segregation errors. The correct answer, premature G2/M entry despite incomplete replication, matches as unchecked Cdc25 activation bypasses the checkpoint, leading to errors from unreplicated DNA. A distractor like enhanced G1/S arrest fails by confusing G2/M with G1 checkpoints and ignoring Cdc25's mitotic role, a misconception in checkpoint specificity. For analogous scenarios, trace phosphatase-kinase interactions back to the stressed phase. A reasoning tip is to predict outcomes of constitutive activation: for Cdc25, expect rushed mitosis and genomic instability.
9. A study examines cells treated with a small molecule that prevents formation of the mitotic spindle but also includes an inhibitor of Mad2, a key spindle checkpoint protein. Compared with spindle disruption alone, dual-treated cells show fewer mitotically arrested cells and increased aneuploidy. What outcome is most consistent with Mad2 inhibition in this setting?
   Answer: Checkpoint bypass allowing APC/C activation despite unattached kinetochores, increasing chromosome missegregation This question evaluates spindle checkpoint bypass. Principle: Mad2 in SAC inhibits APC/C until attachment; inhibition allows APC/C despite unattached kinetochores, causing missegregation. Dual treatment reduces arrest and increases aneuploidy vs. spindle alone. Choice B is consistent as Mad2 inhibition bypasses checkpoint, promoting errors. Choice A fails, suggesting strengthened SAC, opposite to inhibition, a misconception of inhibitor effects. In similar studies, quantify arrest and ploidy. Strategy: predict checkpoint disruption outcomes on segregation fidelity.
10. A cancer cell line is treated with a drug that stabilizes p53 by preventing its interaction with MDM2. Within hours, flow cytometry shows increased fraction of cells with 2N DNA content and decreased BrdU incorporation. Which regulatory change is most likely responsible for the observed cell-cycle effect?
    Answer: Upregulation of p21 leading to inhibition of G1/S cyclin–CDK complexes This question assesses p53-mediated cell cycle arrest mechanisms. The principle is that p53 stabilization induces p21, inhibiting G1/S cyclin-CDKs to halt progression and allow DNA repair. The drug stabilizes p53 by blocking MDM2, leading to G1 accumulation (2N DNA) and reduced BrdU (S-phase marker). Choice D is consistent as p21 upregulation inhibits CDK activity, causing the observed G1 arrest. Choice B fails by suggesting telomerase activation extends S phase, a misconception as telomerase maintains telomeres but doesn't directly arrest cycle via p53. In similar problems, identify if the effector (like p21) targets specific CDKs for phase arrest. A strategy is to link tumor suppressors like p53 to downstream inhibitors and their CDK targets.
11. A laboratory compared two populations of cells after transient nutrient deprivation. Population 1 entered a quiescent state and showed low cyclin levels; upon nutrient repletion, cells re-entered the cycle. Population 2 carried a mutation that constitutively activates a G1 cyclin-CDK complex and did not enter quiescence under the same deprivation. Which phase is most likely bypassed in Population 2 under nutrient-poor conditions?
    Answer: G0, due to continued passage through the G1 restriction point This question explores quiescence (G0) regulation and the G1 restriction point's response to nutrient status. The principle is that nutrient deprivation induces G0 entry before the restriction point, but active G1 CDK allows passage into S phase, bypassing quiescence. Population 2 with constitutive G1 cyclin-CDK fails to enter quiescence under deprivation, unlike controls. The correct answer, bypassing G0 due to continued restriction point passage, fits as unchecked CDK activity prevents G0 arrest. A distractor like S-phase bypass fails by assuming replication defects instead of G1 deregulation, misconstruing nutrient sensing. For such questions, differentiate G0 from cycling phases by cyclin levels. Reason by predicting if mutations sustain progression signals, leading to bypassed arrest states.
12. In a checkpoint disruption experiment, cells are treated with a compound that inhibits the phosphatase Cdc25. Shortly after treatment, immunoassays show CDK1 remains phosphorylated on inhibitory sites, and cells accumulate with 4N DNA content. Which phase transition is most likely blocked?
    Answer: G2 to M transition due to failure to activate cyclin B–CDK1 This question evaluates G2/M transition regulation by phosphatases. Cdc25 principle: dephosphorylates inhibitory sites on CDK1, enabling cyclin B-CDK1 activation for mitosis; inhibition keeps CDK1 inactive, causing G2 arrest. Treatment shows inhibitory CDK1 phosphorylation and 4N accumulation. Choice C is consistent as failed CDK1 activation blocks G2/M transition. Choice B is incorrect, suggesting S/G2 stall from replication issues, but 4N indicates completed S, misconstruing Cdc25's mitotic role. For verification, note 4N DNA with no mitosis points to G2 block. Strategy: link phosphatase/kinase to specific CDK and phase.
13. To probe the G1/S transition, investigators overexpressed a constitutively active CDK4 in epithelial cells cultured with limited growth factors. Immunoblotting shows increased phosphorylation of Rb relative to controls, and BrdU incorporation increases despite the nutrient-poor conditions. Which regulatory protein is most directly affected downstream of Rb phosphorylation to permit S-phase gene expression?
    Answer: E2F transcription factor, released from Rb-mediated inhibition to promote S-phase entry This question tests understanding of the G1/S transition regulatory cascade, specifically how CDK4 phosphorylation of Rb releases E2F transcription factors. CDK4-cyclin D complexes phosphorylate Rb protein during G1, which causes Rb to release E2F transcription factors that then activate S-phase genes required for DNA synthesis. In this experiment, constitutively active CDK4 bypasses normal growth factor requirements by directly phosphorylating Rb, leading to E2F activation and S-phase entry as evidenced by BrdU incorporation. The correct answer A identifies E2F as the key downstream effector released from Rb inhibition to promote S-phase gene expression. Option B (APC/C) and option C (cohesin) are involved in mitosis, not G1/S; option D (telomerase) is not directly regulated by Rb phosphorylation or required for normal S-phase entry. For G1/S transition questions, remember the canonical pathway: growth factors → cyclin D/CDK4,6 → Rb phosphorylation → E2F release → S-phase genes → DNA synthesis.
14. A phase-transition study synchronizes cells at the G1/S boundary, then releases them into S phase. A subset is treated with a drug that blocks DNA polymerase activity. Treated cells show persistent high cyclin A levels and do not enter mitosis on schedule. Which explanation best accounts for delayed mitotic entry?
    Answer: Incomplete DNA replication activates checkpoints that prevent full activation of cyclin B–CDK1 This question examines intra-S checkpoint effects on mitotic entry. Principle: Incomplete replication activates checkpoints inhibiting CDK1, preventing mitosis until resolution; polymerase block sustains cyclin A, delaying entry. Treated cells show high cyclin A and no mitosis. Choice D is consistent as checkpoints block cyclin B-CDK1 activation. Choice B fails, suggesting APC/C activation causes degradation, but high cyclin indicates arrest, misconstruing as exit promoter. For verification, note cyclin persistence and phase markers. Strategy: differentiate replication blocks from post-S events by cyclin types.
15. Following ultraviolet (UV) exposure, a cell line shows rapid activation of ATR and phosphorylation of Chk1. When Chk1 is pharmacologically inhibited, cells proceed into mitosis with unrepaired DNA lesions and display increased chromosome breaks. Which checkpoint is most directly compromised by Chk1 inhibition in this setting?
    Answer: G2/M DNA damage checkpoint that restrains CDK1 activation until repair is complete This question assesses DNA damage checkpoints involving ATR-Chk1. The principle is ATR activates Chk1 after UV damage, inhibiting Cdc25 to phosphorylate CDK1 and enforce G2/M arrest for repair. UV exposure activates ATR-Chk1; inhibiting Chk1 allows mitotic entry with lesions, causing breaks. Choice A is consistent as Chk1 inhibition compromises G2/M checkpoint, permitting mitosis with damage. Choice B is wrong, focusing on spindle checkpoint irrelevant to DNA damage, a misconception blending checkpoints. For similar scenarios, identify damage type (UV for ATR) and effector (Chk1 for G2). Strategy: trace kinase cascade to CDK target and phase affected.
16. Cells are engineered to express a noncleavable form of cohesin that cannot be removed from sister chromatids. Microscopy shows normal chromosome condensation and spindle formation, but chromatids fail to separate and cells do not progress to telophase. Which step is most directly blocked?
    Answer: Metaphase to anaphase transition due to inability to separate sister chromatids This question evaluates cohesin function in chromosome segregation. Principle: cohesin holds sister chromatids; its cleavage by separase (post-securin degradation) enables anaphase separation. Noncleavable cohesin allows condensation/spindle but blocks separation, halting at metaphase. Choice B is consistent as persistent cohesin prevents chromatid separation. Choice A fails, suggesting S-phase entry block unrelated to cohesin, misconstruing as replication factor. For verification, use microscopy for segregation defects. Strategy: distinguish cohesion (holding) from condensation (packaging) roles.
17. Researchers treated cells with a microtubule-depolymerizing drug and observed accumulation of cyclin B and high CDK1 activity. Live-cell imaging showed prolonged chromosome condensation without chromatid separation. Which regulatory mechanism most likely explains the failure to proceed through mitosis?
    Answer: Activation of the spindle assembly checkpoint inhibits APC/C, preventing cyclin B degradation This question evaluates the spindle assembly checkpoint (SAC) in mitotic regulation. The principle is that unattached kinetochores activate SAC to inhibit APC/C, preventing cyclin B degradation and anaphase onset until alignment. The microtubule drug causes cyclin B accumulation and prolonged condensation without separation, indicating SAC activation. The correct answer, SAC inhibiting APC/C to prevent cyclin B degradation, is consistent as it explains sustained CDK1 activity blocking progression. A distractor like p53 inactivation accelerating S phase fails by misapplying DNA damage checkpoints to mitosis, ignoring spindle defects. In similar cases, link drug effects to checkpoint activation and protein stability. A strategy is to associate high cyclin levels with pre-anaphase blocks, distinguishing from post-anaphase issues.
18. Investigators introduce a loss-of-function mutation in the gene encoding p16 (an inhibitor of CDK4/6) in a population of human keratinocytes. Compared with controls, mutant cells show increased phosphorylation of Rb and earlier expression of S-phase genes after mitogen stimulation. Which regulatory mechanism best explains these findings?
    Answer: Reduced inhibition of CDK4/6 promotes Rb phosphorylation and E2F release at the G1 restriction point This question examines CDK inhibitors like p16 in G1 progression. The principle is p16 inhibits CDK4/6, preventing Rb phosphorylation and E2F release; loss allows unchecked CDK activity and early S-gene expression. Mutant keratinocytes show increased Rb phosphorylation and premature S-phase genes post-mitogen. Choice A is consistent as reduced p16 inhibition promotes CDK4/6, Rb phosphorylation, and G1/S progression. Choice B is incorrect, describing CDK1 inhibition which delays mitosis, not G1 effects, a common mix-up of CDK types. For similar questions, recall inhibitor-CDK specificity: p16 for G1 CDKs. Verify by linking mutation to phosphorylation changes and gene expression timing.
19. A lab investigates the spindle assembly checkpoint (SAC) by treating cultured cells with a microtubule-depolymerizing agent. Immunoblotting shows high cyclin B levels and sustained CDK1 activity, with cells remaining rounded and condensed-chromosome morphology. Which outcome is most consistent with an intact SAC under these conditions?
    Answer: Arrest in metaphase due to inhibited APC/C activation until kinetochores are properly attached This question tests the spindle assembly checkpoint (SAC) function. The SAC principle delays anaphase by inhibiting APC/C until kinetochores attach to spindles, maintaining high cyclin B-CDK1. Microtubule depolymerization disrupts spindles, activating SAC and causing mitotic arrest with high cyclin B. Choice B is consistent as intact SAC arrests in metaphase by inhibiting APC/C, sustaining CDK1 activity. Choice A fails by suggesting premature APC/C activation, opposite to SAC's role, a misconception equating spindle disruption to mitotic exit. In similar experiments, check cyclin levels: persistent high indicates checkpoint activation. A strategy is to distinguish checkpoint arrests by morphology and protein markers.
20. In a study of proliferating human fibroblasts, investigators exposed cells to ionizing radiation (IR) and measured cell-cycle distribution 6 hours later. Control cells showed a marked accumulation in G1, whereas cells pretreated with a small-molecule inhibitor of ATM kinase showed minimal G1 accumulation and instead progressed into S phase with elevated markers of replication stress. Which outcome is most consistent with inhibition of the DNA-damage checkpoint described? Assume ATM normally activates a tumor suppressor pathway that limits cyclin-dependent kinase activity after double-strand breaks.
    Answer: Failure to arrest at the G1/S checkpoint due to reduced p53-dependent induction of CDK inhibitors This question tests understanding of DNA damage checkpoints in cell cycle regulation. The principle assessed is how ATM kinase activates p53 to induce CDK inhibitors like p21, arresting cells at G1/S after DNA damage to allow repair. In this scenario, ionizing radiation causes double-strand breaks, normally leading to G1 accumulation via ATM-p53-p21 pathway, but ATM inhibition prevents this arrest. Choice B is consistent because inhibiting ATM reduces p53 activation and CDK inhibitor induction, allowing progression into S phase with replication stress. Choice A fails as it describes mitotic regulation unrelated to G1/S checkpoint or ATM's primary role, a common misconception linking all checkpoints to cyclin degradation. To verify similar questions, recall that ATM/ATR kinases primarily act on G1/S and G2/M checkpoints via p53 and Chk1/2. A useful strategy is to map the damage type to the sensor kinase and downstream effectors for checkpoint specificity.

Start this quiz